Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

M Lippman

Showing results (211-220 of 551) with videos related to

Pageof 56
Sort By:
Cancer Epidemiology, Biomarkers & Prevention : a Publication of the American Association for Cancer Research, Cosponsored by the American Society of Preventive Oncology|June 13, 2001
Identification of retinamides that are more potent than N-(4-hydroxyphenyl)retinamide in inhibiting growth and inducing apoptosis of human head and neck and lung cancer cellsS Y Sun, P Yue, G J Kelloff, et al.
Cancer Epidemiology, Biomarkers & Prevention : a Publication of the American Association for Cancer Research, Cosponsored by the American Society of Preventive Oncology|January 1, 1994
Reduction in oral mucosa micronuclei frequency following alpha-tocopherol treatment of oral leukoplakiaS E Benner, M J Wargovich, S M Lippman, et al.
The Journal of Urology|September 8, 2001
SELECT: the next prostate cancer prevention trial. Selenum and Vitamin E Cancer Prevention TrialE A Klein, I M Thompson, S M Lippman, et al.
Seminars in Oncology|January 14, 1998
Recent advances in paclitaxel-containing chemotherapy for recurrent or metastatic squamous cell carcinoma of the head and neckD M Shin, B S Glisson, F R Khuri, et al.
Urologic Oncology|April 10, 2003
SELECT: the selenium and vitamin E cancer prevention trialEric A Klein, Ian M Thompson, Scott M Lippman, et al.
Journal of the American Dental Association (1939)|January 1, 1995
Co-carcinogenesis and field cancerization: oral lesions offer first signsG L Hays, S M Lippman, C M Flaitz, et al.
Carcinogenesis|June 6, 2012
Systematic evaluation of apoptotic pathway gene polymorphisms and lung cancer riskJie Lin, Charles Lu, David J Stewart, et al.
Cancer Epidemiology, Biomarkers & Prevention : a Publication of the American Association for Cancer Research, Cosponsored by the American Society of Preventive Oncology|June 13, 2001
p53 protein accumulation and genomic instability in head and neck multistep tumorigenesisD M Shin, N Charuruks, S M Lippman, et al.
Annals of Oncology : Official Journal of the European Society for Medical Oncology|January 1, 1996
A phase I investigation of the sequential use of methotrexate and paclitaxel with and without G-CSF for the treatment of solid tumorsM H Huber, J S Lee, R A Newman, et al.
The Journal of Biological Chemistry|August 6, 2003
Alleviating the suppression of glycogen synthase kinase-3beta by Akt leads to the phosphorylation of cAMP-response element-binding protein and its transactivation in intact cell nucleiThomas R Salas, Shrikanth A Reddy, John L Clifford, et al.
Pageof 56

Showing results (211-220 of 551) with videos related to

Sort By:
Pageof 56
Cancer Epidemiology, Biomarkers & Prevention : a Publication of the American Association for Cancer Research, Cosponsored by the American Society of Preventive Oncology|June 13, 2001
Identification of retinamides that are more potent than N-(4-hydroxyphenyl)retinamide in inhibiting growth and inducing apoptosis of human head and neck and lung cancer cellsS Y Sun, P Yue, G J Kelloff, et al.
Cancer Epidemiology, Biomarkers & Prevention : a Publication of the American Association for Cancer Research, Cosponsored by the American Society of Preventive Oncology|January 1, 1994
Reduction in oral mucosa micronuclei frequency following alpha-tocopherol treatment of oral leukoplakiaS E Benner, M J Wargovich, S M Lippman, et al.
The Journal of Urology|September 8, 2001
SELECT: the next prostate cancer prevention trial. Selenum and Vitamin E Cancer Prevention TrialE A Klein, I M Thompson, S M Lippman, et al.
Seminars in Oncology|January 14, 1998
Recent advances in paclitaxel-containing chemotherapy for recurrent or metastatic squamous cell carcinoma of the head and neckD M Shin, B S Glisson, F R Khuri, et al.
Urologic Oncology|April 10, 2003
SELECT: the selenium and vitamin E cancer prevention trialEric A Klein, Ian M Thompson, Scott M Lippman, et al.
Journal of the American Dental Association (1939)|January 1, 1995
Co-carcinogenesis and field cancerization: oral lesions offer first signsG L Hays, S M Lippman, C M Flaitz, et al.
Carcinogenesis|June 6, 2012
Systematic evaluation of apoptotic pathway gene polymorphisms and lung cancer riskJie Lin, Charles Lu, David J Stewart, et al.
Cancer Epidemiology, Biomarkers & Prevention : a Publication of the American Association for Cancer Research, Cosponsored by the American Society of Preventive Oncology|June 13, 2001
p53 protein accumulation and genomic instability in head and neck multistep tumorigenesisD M Shin, N Charuruks, S M Lippman, et al.
Annals of Oncology : Official Journal of the European Society for Medical Oncology|January 1, 1996
A phase I investigation of the sequential use of methotrexate and paclitaxel with and without G-CSF for the treatment of solid tumorsM H Huber, J S Lee, R A Newman, et al.
The Journal of Biological Chemistry|August 6, 2003
Alleviating the suppression of glycogen synthase kinase-3beta by Akt leads to the phosphorylation of cAMP-response element-binding protein and its transactivation in intact cell nucleiThomas R Salas, Shrikanth A Reddy, John L Clifford, et al.
Pageof 56